Tobacco smoke induces CYP1B1 in the aerodigestive tract

Carcinogenesis

Volumn 25, Issue 11, 2004, Pages 2275-2281

  Port, Jeffrey L ^a   Yamaguchi, Kentaro ^a   Du, Baoheng ^a   De Lorenzo, Mariana ^a   Chang, Mindy ^a   Heerdt, Paul M ^a   Kopelovich, Levy ^b   Marcus, Craig B ^c   Altorki, Nasser K ^a   Subbaramaiah, Kotha ^a,d   Dannenberg, Andrew J ^a,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b DCP   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d STRANG CANCER PREVENTION CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450 1B1; LUCIFERASE; MESSENGER RNA; OLIGONUCLEOTIDE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BRONCHUS MUCOSA; CHEMICAL CARCINOGENESIS; COLON; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVITY; ESOPHAGUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; TONGUE;

ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DIGESTIVE SYSTEM; ENZYME INDUCTION; HUMANS; LUNG NEOPLASMS; RESPIRATORY SYSTEM; RNA, MESSENGER; SMOKE; SMOKING;

EID: 8844222721     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh243     Document Type: Article

References (38)

1. Hecht,S.S. (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol., 3, 461-469.
2. Denissenko,M.F., Pao,A., Tang,M.-S. and Pfeifer,G.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
3. Guengerich,F.P. and Shimada,T. (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutat. Res., 400, 201-213.
4. Savas,U., Bhattacharyya,K.K., Christou,M., Alexander,D.L. and Jefcoate,C.R. (1994) Mouse cytochrome P450EF, a representative of a new 1B subfamily of cytochrome P450s. Cloning, sequence determination and tissue expression. J. Biol. Chem., 269, 14905-14911.
5. Sutter,T.R., Tang,Y.M., Hayes,C.L., Wo,Y.Y., Jabs,E.W., Li,X., Yin,H., Cody,C.W. and Greenlee,W.F. (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269 13092-13099.
6. Ding,X. and Kaminsky,L.S. (2003) Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol., 43, 149-173.
7. Hughes,S.J., Morse,M.A., Weghorst,C.M., Kim,H., Watkins,P.B., Guengerich,F.P., Orringer,M.B. and Beer,D.G. (1999) Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia. Neoplasia 1, 145-153.
8. Murray,G.I., Taylor,M.C., McFadyen,M.C., McKay,J.A., Greenlee,W.F., Burke,M.D. and Melvin,W.T. (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res., 57, 3026-3031.
9. Gibson,P., Gill,J.H., Khan,P.A. et al. (2003) Cytochrorne P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development. Mol. Cancer Ther., 2, 527-534.
10. Lin,P., Chang,H., Ho,W.L., Wu,M.H. and Su,J.M. (2003) Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers. Lung Cancer, 42, 255-261.
11. Shimada,T., Hayes,C.L., Yamazaki,H., Amin,S., Hecht,S.S., Guengerich,F.P. and Sutter,T.R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56 2979-2984.
12. Crespi,C.L., Penman,B.W., Steimer,D.T., Smith,T., Yang,C.S. and Sutter,T.R. (1997) Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens. Mutagenesis, 12, 83-89.
13. Li,D.N., Seidel,A., Pritchard,M.P., Wolf,C.R. and Friedberg,T. (2000) Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol. Pharmacogenetics, 10, 343-353.
14. Josephy,P.D., Batty,S.M. and Boverhof,D.R. (2001) Recombinant human P450 forms 1A1, 1A2 and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli LacZ strains. Environ. Mol. Mutagen., 38, 12-18.
15. Kim,J.H., Stansbury,K.H., Walker,N.J., Trush,M.A., Strickland,P.T. and Sutter,T.R. (1998) Metabolism of benzo[a]pyrene and benzo[a]-pyrene-7, 8-diol by human cytochrome P450 1B1. Carcinogenesis, 19, 1847-1853.
16. Spink,D.C., Katz,B.H., Hussain,M.M., Spink,B.C., Wu,S.J., Liu,N., Pause,R. and Kaminsky,L.S. (2002) Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite. Drug Metab. Dispos., 30, 262-269.
17. Murray,G.I., Melvin,W.T., Greenlee,W.F. and Burke,M.D. (2001) Regulation, function and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol., 41, 297-316.
18. Buters,J.T., Sakai,S., Richter,T. et al. (1999) Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl Acad. Sci. USA, 96, 1977-1982.
19. Buters,J.T., Mahadevan,B., Quintanilla-Martinez,L., Gonzalez,F.J., Greim,H., Baird,W.M. and Luch,A. (2002) Cytochrome P450 1B1 determines susceptibility to dibenzo[a,1lpyrene-induced tumor formation. Chem. Res. Toxicol., 15, 1127-1135.
20. Ko,Y., Abel,J., Harth,V. et al. (2001) Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res., 61, 4398-4404.
21. Hanna,I.H., Dawling,S., Roodi,N., Guengerich,F.P. and Parl,F.F. (2000) Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res., 60, 3440-3444.
22. Mitsudomi,T., Viallet,J., Mulshine,J.L., Linnoila,R.I., Minna,J.D. and Gazdar,A.F. (1991) Mutations of ras genes distinguish a subset of nonsmall cell-lung cancer cell lines from small-cell lung cancer cell lines. Oncogene, 6, 1353-1362.
23. Shimada,Y., Imamura,M., Wagata,T., Yamaguchi,N. and Tobe,T. (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer, 69, 277-284.
24. Sacks,P.G. (1996) Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev., 15, 27-51.
25. Lowry,O.H., Rosebrough,N.J., Farr,A.L. and Randell,R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
26. McKay,J.A., Melvin,W.T., Ah-See,A.K., Ewen,S.W.B., Greenlee,W.F., Marcus,C.B., Burke,M.D. and Murray,G.I. (1995) Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett., 374, 270-272.
27. Dignam,J.D., Martin,P.L., Shastry,B.S. and Roeder,R.G. (1983) Eukaryotic gene transcription with purified components. Methods Enzymol., 101, 582-598.
28. Almahmeed,T., Boyle,J.O., Cohen,E.G. et al. (2004) Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract. Carcinogenesis, 25, 793-799.
29. Tang,Y.M., Wo,Y.Y., Stewart,J., Hawkins,A.L., Griffin,C.A., Sutter,T.R. and Greenlee,W.F. (1996) Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J. Biol. Chem., 271, 28324-28330.
30. Tsuchiya,Y., Nakajima,M. and Yokoi,T. (2003) Critical enhancer region to which AhR/ARMT and Sp1 bind in the human CYP1B1 gene. J. Biochem., 133, 583-592.
31. Brake,P.B. and Jefcoate,C.R. (1995) Regulation of cytochrome P4501B1 in cultured rat adrenocortical cells by cyclic adenosine 3′,5′-monophosphate and 2,3,7,8-tetrachlorodibenzo-dioxin. Endocrinology, 136, 5034-5041.
32. Tsuchiya,Y., Nakajima,M., Kyo,S., Kanaya,T., Inoue,M. and Yokoi,T. (2004) Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res., 64, 3119-3125.
33. Willey,J.C., Coy,E.L., Frampton,M.W. et al. (1997) Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1 and 2B7, microsomal epoxide hydrolase and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am. J. Respir. Cell Mol. Biol., 17, 114-124.
34. Guengerich,F.P., Chun,Y.J., Kim,D., Gillam,E.M. and Shimada,T. (2003) Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat. Res., 523/524, 173-182.
35. McFayden,M.C.E., Melvin,W.T. and Murray,G.I. (2004) Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol. Cancer Ther., 3, 363-371.
36. Maecker,B., Sherr,D.H., Vonderheide,R.H. et al. (2003) The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood, 102, 3287-3294.
37. McFadyen,M.C., McLeod,H.L., Jackson,F.C., Melvin,W.T., Doehmer,J. and Murray,G.I. (2001) Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. Biochem. Pharmacol., 62, 207-212.
38. Albanes,D., Heinonen,O.P., Taylor,P.R. et al. (1996) α-Tocopherol and β-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl Cancer Inst. 88, 1560-1570.